Advertisement

Prevalence of Hepatitis C Virus Infection Among Haemodialysis Patients in West Java, Indonesia

Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 531)

Abstract

Hepatotropic infections, such as those caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), are a major health problem in developing countries in South East Asia. In Indonesia, for example, there is a high prevalence (approximately 8-36%) of chronic HBV infections. Fortunately, with improved HBV control strategies, the carrier rate has declined in the past decade (Soelaiman, 1993).

Keywords

Dialysis Patient Haemodialysis Patient Continuous Ambulatory Peritoneal Dialysis Dialysis Unit Dialysis Centre 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alivanis, P., Derveniotis, V., Dioudis, C., Grekas, D., Mandraveli, P., Vasiliou, S., and, Tourkantonis, A., 1991, Hepatitis C virus antibodies in haemodialysed and in renal transplant patients: correlation with chronic liver disease. Transplant. Proc. 23 2662–2663.PubMedGoogle Scholar
  2. Allander, T., Medin, C., Jacobson, S.H., Grillner, L., and Persson, M.A.A., 1994, Hepatitis C transmission in a haemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J. Med. Virol. 43 415–419.PubMedCrossRefGoogle Scholar
  3. Alonso, M., Nova, D., Romero, R., Arcocha, V., and Sanche-Guisande, D., 1991, Antibodies to hepatitis C virus in patients on haemodialysis. Nephron 57 247.PubMedCrossRefGoogle Scholar
  4. Bukh, J., Wantzin, P., Krogsgarrd, K., Knudsen, F., Purcell, R.H., and Miller, R.H., 1993, High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV study Group. J. Infect. Dis. 168 1343–1348.PubMedCrossRefGoogle Scholar
  5. Brugnano, R., Fransisci, D., Quintaliani, G., Gaburri, M., Nori, G., Verdura, C., Giombini, L., and Buonsristiani, U., 1992, Antibodies against hepatitis C virus in haemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors. Nephron 61 263265.Google Scholar
  6. Cantu, P., Mangano, S., Masini, M., Limido, A., Crovetti, G., and DeFilippo, C., 1992, Prevalence of antibodies against hepatitis C virus in a dialysis unit. Nephron 61 337–338.Google Scholar
  7. Chan, T.M., Lok, A.S.F., and Cheng, I.K.P., 1991, Hepatitis C infection among haemodialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 6 944–947.PubMedCrossRefGoogle Scholar
  8. Chan, T.M., Lok, A.S.F., Cheng, I.K.P, and Chan, R.T., 1993, Prevalence of hepatitis C virus infection in haemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 17 5–8.PubMedCrossRefGoogle Scholar
  9. Chan, T.M., Lok, A.S.F., Cheng, I.K.P., and Chan, R.T., 1993, A prospective study of hepatitis C virus infection among renal transplant patients. Gastroenterolgy 104 862–868.Google Scholar
  10. Chauveau, P., Courouce, A.M., Lemarec, N., Naret, C., Poignet, J.L., Girault, A., Ramdane, M., and Delons, S., 1993, Antibodies to hepatitis C virus by second generation test in haemodialysed patients. Kidney Int. 43 149–15.Google Scholar
  11. da Silva Cardoso, M., Koerner, M., Epple, S., Kramer, R., Bundschu, D., and Kubanek, B., 1994, Prevalence of HCV-RNA-positive patients in a dialysis unit in Germany. Nephron 68 517–518.CrossRefGoogle Scholar
  12. Dentico, P., Volpe, A., Bungiorno, R., Carlone, A., Carbone, M., and Manno, M., 1992, Hepatitis C virus in haemodialysis patients. Nephron 61 307–308.PubMedCrossRefGoogle Scholar
  13. Dusssol, B., Berthizene, P., Brunet, P., Roubicek, C., and Berland, Y., 1995, Hepatitis C virus infection among chronic dialysis patients in the South of France: a collaborative study. Am. J. Kidney Dis. 25 399–404.CrossRefGoogle Scholar
  14. Fujiyama, S., Kawano, S., Sato, S., Shimada, H., Matsuhita, K., Ikezaki, N., Nakano, T., and Sato, T., 1995, Changes in prevalence of anti-HCV antibodies associated with preventive measures among haemodialysis patients and staff. Hepatogastroenterology 42 162–165.PubMedGoogle Scholar
  15. Huraib, S., al-Rashed, R., Aldrees, A., Aljefry, M., Arif, M., and al-Faleh, F.A., 1995, High prevalence of anti-HCV and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol. Dial. Transplant. 10 470–474.PubMedGoogle Scholar
  16. Irie, Y., Hayashi, H., Yokozeki, K., Kashima, T., and Okuda, K., 1994, Hepatitis C infection unrelated to blood transfusion in haemodialysis patients. J. Hepatol. 20 557–559.PubMedCrossRefGoogle Scholar
  17. Jadoul, M., Cornu, C., van Ypersele de Strihou, C., and the UCL Collaborative Group, 1993, Incidence and risk factors for seroconversion in haemodialysis: a prospective study. Kidney Int. 44 1322–1326.CrossRefGoogle Scholar
  18. Jemni, S., Ikbel, K., Mahjoub, J., Ghachem, L., Bidet, J.M., and Boukef, K., 1994, Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Nouv. Rev. Fr. Hematol. 36, 349–351.PubMedGoogle Scholar
  19. Knudsen, F., Wantzin, P., Rasmussen, K. et al., 1993, Hepatitis C in dialysis patients: relationship to blood transfusion, dialysis and liver disease. Kidney. Int. 43 1353–1356.PubMedCrossRefGoogle Scholar
  20. Keur, I., Schneeberger, P., Van der Graaf, Y., Vos, J., van Dijk, W., and van Doorn, L.J., 1997, Risk factors for HCV-infection in two dialysis units in the Netherlands. Neth. J. Med. 50 97–101.PubMedCrossRefGoogle Scholar
  21. Moroni, G.A., Cori, P., Marelli, F., et al., 1991 Indirect evidence for transfusin role in conditioning hepatitis C virus prevalence among dialysis patients. Nephron 57 371–337.PubMedCrossRefGoogle Scholar
  22. Perez-Fontain, M., Moncalian, J., Rodriguez-Carmona, A., and Arrojo, F., 1991, Prevalence of antihepatitis C antibodies in patients treated with continuous ambulatory peritoneal dialysis and haemodialysis. Nephron 58 381–382.CrossRefGoogle Scholar
  23. Ponz, E., Campistol, J.M., Barrera, J. et al., 1991, Hepatitis C virus antibodies in patients on haemodialysis and after kidney transplantation. Transplant. Proc. 23 1371–1372.PubMedGoogle Scholar
  24. Saketi, J.R., 1996, Prevalence of hepatitis C virus infection on haemodialysis patients in the Renal Unit of Dr. Hasan Sadikin General Hospital in Bandung, West Java. The 7th National Congress of the Indonesian Society of Gastroenterology and the Indonesian Society of Digestive Endoscopy & the 8th Scientific Meeting of the Indonesian Association for the Study of Liver, Bali, Abstract.Google Scholar
  25. Sampietro, M., Badalamenti, S., Salvadori, S., Corbetta, N., Graziani, G., Como, G., Fiorelli, G., and Ponticelli, C., 1995, High prevalence of a rare hepatitis C virus in patients treated in the same haemodialysis units: evidence for nosocomial transmission of HCV. Kidney. Int. 47 911–917.PubMedCrossRefGoogle Scholar
  26. Schlipkoter, U., Roggendorf, M., Ernst, G., et al.,1990, Hepatitis C virus antibodies in haemodialysis patients (Letter). Lancet 335 1409.CrossRefGoogle Scholar
  27. Schneeberger, P.M., Vos, J., and van Dijk, W.C., 1993, Prevalence of antibodies to hepatitis C virus in a Dutch group of haemodialysis patients related to risk factors. J. Hosp. Infect. 25 265–270.PubMedCrossRefGoogle Scholar
  28. Schneeberger, P.M., 1999, Hepatitis C virus infections in dialysis patients in The Netherlands. Thesis. Utrecht University, 1999, pp. 89–108.Google Scholar
  29. Simon, N., Courouce, A.M., Lemarrec, N., Trepo, C., and Ducamp, S., 1994, A twelve year natural history of hepatitis C virus infection in haemodialyzed patients. Kidney Int. 46 504–511.PubMedCrossRefGoogle Scholar
  30. Soelaiman, A., 1993, Hepatitis menjelang tahun 2000. Pidato Pengukuhan Jabatan Guru Besar FKUI, Jakarta.Google Scholar
  31. Stuyver, L., Claeys, H., Wyseur, A., Arnhem, W.V., De Beenhouver, H., Uytendaele, S., Beckers, J., Matthijs, D., Leroux-Roels, G., Maertens, G., and De Paepe, M., 1996, Hepatitis C virus in haemodialysis unit: molecular evidence for nosocomial transmission. Kidney Int. 49 889–895.PubMedCrossRefGoogle Scholar
  32. Teruel, J., Pasqual, J., Liano, F., and Ortuno, J., 1992, Importance of nosocomial transmission of hepatitis C virus in dialysis units. Clin. Nephrol. 38 177–178.PubMedGoogle Scholar
  33. van der Poel, C.L., Reesink, H.W., Mauser Bunschoten, E.P., Kaufman, R.H., Leentvaar Kuypers, A., Chamuleau, R.A., Schaasberg, W., Bakker, E., Exel Oehlers, P.J., Theobald, I, et al., 1991, Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands. Vox Sang. 61 30–36PubMedCrossRefGoogle Scholar
  34. Yamaguchi, K., Nishimura, Y., Machida, J., Ueda, S., Kusumoto, Y., Futami, G., Ishii, T., and Takatsuki, K., 1990, Hepatitis C virus antibodies in haemodialysis patients. Lancet 335: 1409–1410.CrossRefGoogle Scholar
  35. Yoshida, C.F.T., Vanderborght, B.O.M., Stuyver, L., Takakashi, C., Rouzere, C.D., and Maertens, G., 1993, Tracing non-transfusional transmission of HCV infection through genomic typing of HCV in haemodialysis unit. 8th International Symposium on Viral Hepatitis and Liver Disease,1993 Tokyo, Abstract 581Google Scholar
  36. Zeldis, J.B., Depner, T.A., Kuramoto, I.K., et al., 1990, The prevalence of hepatitis C virus antibodies in haemodialysis patients. Ann. Intern. Med. 112: 958–960.PubMedGoogle Scholar
  37. Zeuzem, S., Scheuermann, E.H., Waschk, D., et al., 1996, Phylogenetic analysis of hepatitis C virus isolated from haemodialysis patients. Kidney Int. 49: 896–902.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  1. 1.Divisions of Gastroentero-Hepatology, Department of Internal Medicine, Faculty of MedicinePadjadjaran University, Dr Hasan Sadikin General HospitalBandungIndonesia
  2. 2.Department of VirologyUniversity Medical Centre of UtrechtUtrechtThe Netherlands
  3. 3.Department of Gastroenterology-HepatologyUniversity Medical Centre of UtrechtUtrechtThe Netherlands
  4. 4.Divisions of Nephrology-Hypertension, Department of Internal Medicine, Faculty of MedicinePadjadjaran University, Dr Hasan Sadikin General HospitalBandungIndonesia

Personalised recommendations

Cite chapter

Buy options